[1] Jariwala P, Chandra S. Diagnosis and management of failed thrombolytic therapy for acute myocardial infarction [J]. Indian Heart J, 2010, 62(1):21-28. [2] Prasad A, Herrmann J. Myocardial infarction due to percutaneous coronary intervention [J]. N Engl J Med, 2011, 364(5): 453-464. [3] Mirotsou M, Jayawardena TM, Schmeckpeper J, et al. Paracrine mechanisms of stem cell reparative and regenerative actions in the heart [J].Journal of Molecular and Cellular Cardiology, 2011; 50(2): 280-289. [4] Menasche´ P. Stem cell therapy for chronic heart failure. Lessons from a 15-year experience [J]. Comptes Rendus Biologies,2011, 334 (5) 489-496. [5] Cui XJ, Wang HJ, Guo HD, et al. Transplantation of mesenchymal stem cells preconditioned with diazoxide, a mitochondrial ATP-sensitive potassium channel opener, promotes repair of myocardial infarction in rats [J]. Tohoku J Exp Med, 2010, 220 (1):139-147. [6] Cui XJ, Xie H, Wang HJ, et al. Transplantation of mesenchymal stem cells with self-assembling polypeptide scaffolds is conducive to treating myocardial infarction in rats [J]. Tohoku J Exp Med, 2010, 220(4), 281-289. [7] Lai RC, Arslan F, Lee MM, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury [J].Stem Cell Res, 2010, 4( 3) : 214-222. [8] Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease [J]. Regen Med, 2011, 6( 4) : 481-492. [9] Timmers L, Lim SK, Arslan F, et al. Reduction of myocardial infract size by human mesenchymal stem cell conditioned medium [J]. Stem cell Res, 2007, 1(2) : 129-137. [10]Simons M, Raposo G. Exosomes-vesicular carriers for intercellular communication [J]. Curr Opin Cell Biol, 2009, 21(4): 575- 581. [11]Chen TS, Lai RC, Lee MM, et al. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs [J].Nucleic Acids Res, 2010, 38(1) : 215-224.
|